Francois Michelon
Francois Michelon is a healthcare technology professional[1] who currently serves as the CEO and Board Chairman of ENDRA Life Sciences (Nasdaq: NDRA). ENDRA Life Sciences is a company that specializes in the early detection of liver diseases using Thermo Acoustic Enhanced Ultrasound (TAEU) technology.[2]
| Francois Michelon | |
 | |
| Born | United States |
|---|---|
| Occupation | Businessman |
| Contact | |
Early Life and Education
Michelon obtained a Bachelor of Arts degree (BA) in Economics at the University of Chicago. Afterwards, he went on to obtain a Master of Business Administration degree (MBA) at Carnegie Mellon University in Pittsburgh, Pennsylvania. Michelon also obtained a Six Sigma Black Belt in Business Process Improvement.[3]
Career
Between 1997 and 2004, Michelon started his career by taking on global marketing, e-business, and six sigma roles at GE Health (NYSE: GE), a provider of medical technology specializing in health diagnosis, monitoring, and treatment.[4]
Michelon is the current CEO and Board Chairman of ENDRA Life Sciences, a position that he took on in 2015.[5][6] Additionally, he has worked at other companies such as Smith and Nephew Advanced Surgical Devices and Biomet 3i before joining ENDRA Life Sciences.[7][8]
References
- ^ ENDRA Life Sciences Inc. The Wall Street Journal.
- ^ LinkedIn.
- ^ LinkedIn.
- ^ LinkedIn.
- ^ Francois Michelon biography. Wallmine.
- ^ https://www.ptcommunity.com/wire/top-companies-watch-fight-against-breast-cancer-2020 The Top Companies to Watch in the Fight Against Breast Cancer in 2020]. P&T Community.
- ^ LinkedIn.
- ^ Francois Michelon.